Position in TMO
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$80,718
+$2,074 QoQ
Shares Held
161
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#2,382
of 2,606 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Evolution Advisers, Inc. holds $91,565 across 7 Diagnostics & Research names. TMO ranks #1 (88.2% of the industry book) .
All Filings in TMO
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $80,718 | 161 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $78,644 | 160 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $92,712 | 160 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $77,603 | 160 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $64,873 | 160 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $79,616 | 160 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $83,236 | 160 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $98,971 | 160 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $88,480 | 160 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $92,993 | 160 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $84,926 | 160 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $80,987 | 160 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $83,480 | 160 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $92,219 | 160 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $88,110 | 160 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $81,150 | 160 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $86,924 | 160 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $94,504 | 160 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $106,758 | 160 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||